Consensus InspireMD, Inc.

Equities

NSPR

US45779A8466

Delayed Nasdaq Other stock markets 09:49:45 2024-06-03 am EDT			5-day change	1st Jan Change
2.744 ^USD	-0.23%		+3.53%	-2.36%

May. 14	Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14	Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M	MT

Evolution of the average Target Price on InspireMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1b67f20f9ec8566976a57.NBLo8fOS3nZT86uAN2qCf093Oj6x9G3Z-b_XP_JVYlI.eV-3tJKnrwwaxMjxBRLQSAgcCwjgvBioytriS78nV2F5e4PJo6KmEGaX2A~02fc8ada9796c9de937375b989f863d3

Analyst Recommendations on InspireMD, Inc.

Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	23-06-12	MT
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	23-05-17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.75 USD

Average target price

4.5 USD

Spread / Average Target

+63.64%

High Price Target

4.5 USD

Spread / Highest target

+63.64%

Low Price Target

4.5 USD

Spread / Lowest Target

+63.64%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InspireMD, Inc.

Piper Sandler
Alliance Global Partners

Quarterly earnings - Rate of surprise

Company calendar